Evidence map›Paper›PMID 31172909›Full record

ReviewMicrobiology spectrum2019

Reaching the End of the Line: Urinary Tract Infections.

Kevin O Tamadonfar, Natalie S Omattage, Caitlin N Spaulding, Scott J Hultgren

Open access · greenAbstract readReview
In one paragraph

Review in Microbiology spectrum, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 115 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Cranberry juice potentiates sensitivity of uropathogenicApplied and environmental microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Deep Learning-Based Rapid Identification ofRisk management and healthcare policy · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Emerging roles for ABC transporters as virulence factors in uropathogenicProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kevin O TamadonfarDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Natalie S OmattageDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Caitlin N SpauldingDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Scott J HultgrenDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Washington University in St. Louis · US

Funding

NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
6 · The paper itself

Abstract

Urinary tract infections (UTIs) cause a substantial health care burden. UTIs (i) are most often caused by uropathogenic

Indexed as

Anti-Bacterial AgentsCatheter-Related InfectionsDrug Resistance, BacterialEnterococcusEscherichia coli InfectionsFemaleHumansStaphylococcusUrinary BladderUrinary TractUrinary Tract InfectionsUropathogenic Escherichia coliAnti-Bacterial Agents

Identifiers

PMID31172909
PMCPMC11314827
OpenAlexW2949040766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.